Dr. Alexander Khoruts (University of Minnesota GI, Director, UMN Microbiota Therapeutics Program) made a similar comment. …humanmicrobiome.info/…/designer-hit-panel-discus…
He asks an FDA adviser “Does the FDA care more about profits or people?”, and the response he gets is “one of the missions of the FDA is to protect the interests of commercial developers”. Another question to the advisor: “How much influence does the industry have over the FDA decisions?”, A: “A lot”.